PHVS
Price:
$30.72
Market Cap:
$1.85B
Pharvaris N.V. is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and bringing to market treatments for uncommon diseases. Its primary pipeline asset, PHA121, is a small molecule bradykinin B2-receptor antagonist currently undergoing Phase II clinical trials for hereditary angioedema (HAE). Additionally, the company is advancing PHVS416, a swift-acting, on-demand soft capsule designed to alleviate acute HAE attacks, which is also in Phase 2 development. A third candidate, PHVS719, an extended-release prophylactic tablet aimed at preventing HAE episodes, is progressing through Phase 1 trials. Established in 2015 and headquartered in Leiden, the Netherlands, Ph...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
PHVS
According to Pharvaris N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.60B. This represents a change of 57.62% compared to the average of 1.02B of the last 4 quarters.
The mean historical Enterprise Value of Pharvaris N.V. over the last ten years is 555.61M. The current 1.60B Enterprise Value has changed 28.75% with respect to the historical average. Over the past ten years (40 quarters), PHVS's Enterprise Value was at its highest in in the March 2026 quarter at 1.35B. The Enterprise Value was at its lowest in in the March 2017 quarter at -1198783.00.
Average
555.61M
Median
625.53M
Minimum
-4795135.00
Maximum
1.11B
Discovering the peaks and valleys of Pharvaris N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 204.62%
Maximum Annual Enterprise Value = 1.11B
Minimum Annual Increase = -16778.97%
Minimum Annual Enterprise Value = -4795135.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.11B | 53.62% |
| 2024 | 720.18M | 23.48% |
| 2023 | 583.25M | 204.62% |
| 2022 | 191.47M | 8.94% |
| 2021 | 175.75M | -71.90% |
| 2020 | 625.53M | -22.10% |
| 2019 | 803.03M | 0.41% |
| 2018 | 799.78M | -16778.97% |
The current Enterprise Value of Pharvaris N.V. (PHVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
803.25M
5-year avg
555.39M
10-year avg
555.61M
Pharvaris N.V.’s Enterprise Value is greater than Immunome, Inc. (1.18B), less than Spyre Therapeutics, Inc. (4.78B), greater than Intellia Therapeutics, Inc. (1.30B), greater than Maze Therapeutics, Inc. (1.19B), greater than Upstream Bio, Inc. (236.35M), greater than Zymeworks Inc. (1.46B), less than BioCryst Pharmaceuticals, Inc. (2.51B), less than Vera Therapeutics, Inc. (2.42B), greater than ORIC Pharmaceuticals, Inc. (799.69M), greater than Ardelyx, Inc. (1.58B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.18B | $1.76B | |
| 4.78B | $4.88B | |
| 1.30B | $1.36B | |
| 1.19B | $1.33B | |
| 236.35M | $331.96M | |
| 1.46B | $1.68B | |
| 2.51B | $1.83B | |
| 2.42B | $2.46B | |
| 799.69M | $856.09M | |
| 1.58B | $1.41B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharvaris N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharvaris N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pharvaris N.V.'s Enterprise Value?
What is the highest Enterprise Value for Pharvaris N.V. (PHVS)?
What is the 3-year average Enterprise Value for Pharvaris N.V. (PHVS)?
What is the 5-year average Enterprise Value for Pharvaris N.V. (PHVS)?
How does the current Enterprise Value for Pharvaris N.V. (PHVS) compare to its historical average?